Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8381)
All Articles published online
|
Publishing Process of This Article
|
Feb 7, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lu DH, Guo XY, Qin SY, Luo W, Huang XL, Chen M, Wang JX, Ma SJ, Yang XW, Jiang HX. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines. World J Gastroenterol 2015; 21(5): 1531-1545 [PMID: 25663772 DOI: 10.3748/wjg.v21.i5.1531] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i5/1531.htm |
| Number | Citing Articles |
| 1 |
Aaliya L. Ali, Namrata P. Nailwal, Gaurav M. Doshi. Emerging Role of Interleukins for the Assessment and Treatment of Liver
Diseases. Endocrine, Metabolic & Immune Disorders - Drug Targets 2022; 22(4): 371 doi: 10.2174/1871530321666211124102837
|
| 2 |
Fa-Da Wang, Jing Zhou, En-Qiang Chen. Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.787748
|
| 3 |
Feliciano Chanana Paquissi. Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets. Frontiers in Immunology 2016; 7 doi: 10.3389/fimmu.2016.00490
|
| 4 |
Shi Yin, Dechun Feng. WITHDRAWN: IL-22 in liver inflammation, injury and repair. Liver Research 2018; doi: 10.1016/j.livres.2017.10.001
|
| 5 |
Laura Maggi, Genil Mororó Araújo Camelo, Izabella Chrystina Rocha, William Pereira Alves, João Marcelo Peixoto Moreira, Thiago Almeida Pereira, Wagner Luiz Tafuri, Élida Mara Leite Rabelo, Ary Correa, Roselene Ecco, Deborah Aparecida Negrão-Corrêa. Role of the IL-33/ST2 Activation Pathway in the Development of the Hepatic Fibrosis Induced by Schistosoma mansoni Granulomas in Mice. International Journal of Molecular Sciences 2023; 24(12): 10237 doi: 10.3390/ijms241210237
|
| 6 |
Shaofei Wang, Yubin Li, Jiajun Fan, Xuyao Zhang, Jingyun Luan, Qi Bian, Tao Ding, Yichen Wang, Ziyu Wang, Ping Song, Daxiang Cui, Xiaobin Mei, Dianwen Ju. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation. Cell Death & Disease 2017; 8(7): e2937 doi: 10.1038/cddis.2017.292
|
| 7 |
Abdelghany Hassan Abdelghany, Mohammad A. BaSalamah, Shakir Idris, Jawwad Ahmad, Bassem Refaat. The fibrolytic potentials of vitamin D and thymoquinone remedial therapies: insights from liver fibrosis established by CCl4 in rats. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-1040-4
|
| 8 |
Zhou Lu, Jiajing Liu, Xiaoming Liu, Enyu Huang, Jiao Yang, Jiawen Qian, Dan Zhang, Ronghua Liu, Yiwei Chu. MicroRNA 15a/16‐1 suppresses aryl hydrocarbon receptor–dependent interleukin‐22 secretion in CD4+ T cells and contributes to immune‐mediated organ injury. Hepatology 2018; 67(3): 1027 doi: 10.1002/hep.29573
|
| 9 |
Chong Zhang, Ran An, Ya-Wei Bao, Xiao-Ming Meng, Tian-Qi Wang, Hao-Nan Sun, Fa-Ming Pan, Chao Zhang. Inhibitory effects of octreotide on the progression of hepatic fibrosis via the regulation of Bcl-2/Bax and PI3K/AKT signaling pathways. International Immunopharmacology 2019; 73: 515 doi: 10.1016/j.intimp.2019.05.055
|
| 10 |
Yuting Gu, Yilan Shen, Wei Chen, Haidong He, Yulei Ma, Xiaobin Mei, Dianwen Ju, Hongrui Liu. Protective effects of interleukin-22 on oxalate-induced crystalline renal injury via alleviating mitochondrial damage and inflammatory response. Applied Microbiology and Biotechnology 2022; 106(7): 2637 doi: 10.1007/s00253-022-11876-4
|
| 11 |
Arij Bedoui, Afoua Mufti, Anouar Feriani, Hanene Baccari, Amal Bouallegue, Mohamed Kharrat, Mansour Sobeh, Moez Amri, Zouhaier Abbes. Unlocking the hepatoprotective potential of the parasitic plant Orobanche foetida Poir. aqueous extract against CCl4-induced liver injury in rat. Frontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1320062
|
| 12 |
Han-Jing Zhangdi, Si-Biao Su, Fei Wang, Zi-Yu Liang, Yu-Dong Yan, Shan-Yu Qin, Hai-Xing Jiang. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World Journal of Gastroenterology 2019; 25(33): 4835-4849 doi: 10.3748/wjg.v25.i33.4835
|
| 13 |
Kei Moriya, Norihisa Nishimura, Tadashi Namisaki, Hiroaki Takaya, Yasuhiko Sawada, Hideto Kawaratani, Kosuke Kaji, Naotaka Shimozato, Shinya Sato, Masanori Furukawa, Akitoshi Douhara, Takemi Akahane, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis. Journal of Clinical Medicine 2021; 10(11): 2465 doi: 10.3390/jcm10112465
|
| 14 |
Mohamed M. Hafez, Sherifa S. Hamed, Manal F. El-Khadragy, Zeinab K. Hassan, Salim S. Al Rejaie, Mohamed M. Sayed-Ahmed, Naif O. Al-Harbi, Khalid A. Al-Hosaini, Mohamed M. Al-Harbi, Ali R. Alhoshani, Othman A. Al-Shabanah, Shakir Dekhal Alsharari. Effect of ginseng extract on the TGF-β1 signaling pathway in CCl4-induced liver fibrosis in rats. BMC Complementary and Alternative Medicine 2017; 17(1) doi: 10.1186/s12906-016-1507-0
|
| 15 |
Suxia Bao, Jianming Zheng, Guangfeng Shi. The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis. Molecular Medicine Reports 2017; 16(4): 3713 doi: 10.3892/mmr.2017.7044
|
| 16 |
Virender Kumar, Vinod Kumar, Jiangtao Luo, Ram I. Mahato. Therapeutic Potential of OMe-PS-miR-29b1 for Treating Liver Fibrosis. Molecular Therapy 2018; 26(12): 2798 doi: 10.1016/j.ymthe.2018.08.022
|
| 17 |
Daria M. Kartasheva-Ebertz, Stanislas Pol, Sylvie Lagaye. Retinoic Acid: A New Old Friend of IL-17A in the Immune Pathogeny of Liver Fibrosis. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.691073
|
| 18 |
Reham M. Dawood, Mai A. El-Meguid, Ghada Maher Salum, Mostafa K. El Awady. Key Players of Hepatic Fibrosis. Journal of Interferon & Cytokine Research 2020; 40(10): 472 doi: 10.1089/jir.2020.0059
|
| 19 |
Ruonan Sun, Zheng Xiang, Bin Wu. T cells and liver fibrosis. Portal Hypertension & Cirrhosis 2022; 1(2): 125 doi: 10.1002/poh2.11
|
| 20 |
Yuqi Chen, Huiya Ma, Youwei Du, Jianjian Dong, Chenkai Jin, Lihui Tan, Rong Wei. Functions of 1,25-dihydroxy vitamin D3, vitamin D3 receptor and interleukin-22 involved in pathogenesis of gout arthritis through altering metabolic pattern and inflammatory responses. PeerJ 2021; 9: e12585 doi: 10.7717/peerj.12585
|
| 21 |
Takaaki Higashi, Scott L. Friedman, Yujin Hoshida. Hepatic stellate cells as key target in liver fibrosis. Advanced Drug Delivery Reviews 2017; 121: 27 doi: 10.1016/j.addr.2017.05.007
|
| 22 |
|
| 23 |
Wei Wang, Xuelian Huang, Xuzhou Fan, Jingmei Yan, Jianfeng Luan. Progress in evaluating the status of hepatitis C infection based on the functional changes of hepatic stellate cells (Review). Molecular Medicine Reports 2020; doi: 10.3892/mmr.2020.11516
|
| 24 |
Bang-li Hu, Cheng Shi, Rong-e Lei, Dong-hong Lu, Wei Luo, Shan-yu Qin, You Zhou, Hai-xing Jiang. Interleukin-22 ameliorates liver fibrosis through miR-200a/beta-catenin. Scientific Reports 2016; 6(1) doi: 10.1038/srep36436
|
| 25 |
Juan P. Arab, Tejasav S. Sehrawat, Douglas A. Simonetto, Vikas K. Verma, Dechun Feng, Tom Tang, Kevin Dreyer, Xiaoqiang Yan, William L. Daley, Arun Sanyal, Naga Chalasani, Svetlana Radaeva, Liu Yang, Hugo Vargas, Mauricio Ibacache, Bin Gao, Gregory J. Gores, Harmeet Malhi, Patrick S. Kamath, Vijay H. Shah. An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis. Hepatology 2020; 72(2): 441 doi: 10.1002/hep.31046
|
| 26 |
Yifei Wang, Bin Huang, Tao Jin, Dickson Kofi Wiredu Ocansey, Jiajia Jiang, Fei Mao. Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.835005
|
| 27 |
Mirna Perusina Lanfranca, Yanwei Lin, Jingyuan Fang, Weiping Zou, Timothy Frankel. Biological and pathological activities of interleukin-22. Journal of Molecular Medicine 2016; 94(5): 523 doi: 10.1007/s00109-016-1391-6
|
| 28 |
Zheng Wang, Lichao Yao, Xue Hu, Mengqin Yuan, Ping Chen, Pingji Liu, Qiuling Zhang, Zhiyu Xiong, Kai Dai, Yingan Jiang. Advancements in mesenchymal stem cell therapy for liver cirrhosis: Unveiling origins, treatment mechanisms, and current research frontiers. Tissue and Cell 2023; 84: 102198 doi: 10.1016/j.tice.2023.102198
|
| 29 |
Mengjuan Zhang, Song Zhang. T Cells in Fibrosis and Fibrotic Diseases. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01142
|
| 30 |
Enran Chen, Yu Cen, Donghong Lu, Wei Luo, Haixing Jiang. IL-22 inactivates hepatic stellate cells via downregulation of the TGF-β1/Notch signaling pathway. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8516
|
| 31 |
Ming-Hui Feng, Jian-Wei Li, Hai-Tao Sun, Song-Qi He, Jie Pang. Sulforaphane inhibits the activation of hepatic stellate cell by miRNA-423-5p targeting suppressor of fused. Human Cell 2019; 32(4): 403 doi: 10.1007/s13577-019-00264-2
|
| 32 |
Xiaoming Huang, Zexian Chen, Nanrong Zhang, Caiyan Zhu, Xutao Lin, Jiandong Yu, Zhiping Chen, Ping Lan, Yunle Wan. Increase in CD4+FOXP3+ regulatory T cell number and upregulation of the HGF/c‑Met signaling pathway during the liver metastasis of colorectal cancer. Oncology Letters 2020; 20(3): 2113 doi: 10.3892/ol.2020.11785
|
| 33 |
Wei Wang, Fangfang Li, Xiaoyang Lai, Han Liu, Shuting Wu, Yunqin Han, Yunfeng Shen. Exosomes secreted by palmitic acid-treated hepatocytes promote LX-2 cell activation by transferring miRNA-107. Cell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00536-7
|
| 34 |
Zhuyun Xing, Yayun Wu, Na Liu. IL‑22 alleviates the fibrosis of hepatic stellate cells via the inactivation of NLRP3 inflammasome signaling. Experimental and Therapeutic Medicine 2021; 22(4) doi: 10.3892/etm.2021.10522
|
| 35 |
Ching-Pin Lin, Wen-Chen Chuang, Fung-Jou Lu, Chih-Yen Chen. Anti-oxidant and anti-inflammatory effects of hydrogen-rich water alleviate ethanol-induced fatty liver in mice. World Journal of Gastroenterology 2017; 23(27): 4920-4934 doi: 10.3748/wjg.v23.i27.4920
|
| 36 |
Ali Hazrati, Kosar Malekpour, Sara Soudi, Seyed Mahmoud Hashemi. Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles Application in Acute and Chronic Inflammatory Liver Diseases: Emphasizing on the Anti-Fibrotic and Immunomodulatory Mechanisms. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.865888
|
| 37 |
Zhigao Hu, Huizhao Su, Yonglian Zeng, Chengjie Lin, Zhenya Guo, Fudi Zhong, Keqing Jiang, Guandou Yuan, Songqing He. Tetramethylpyrazine ameliorates hepatic fibrosis through autophagy-mediated inflammation. Biochemistry and Cell Biology 2020; 98(3): 327 doi: 10.1139/bcb-2019-0059
|
| 38 |
Tanzeela Arshad, Fizzah Mansur, Richard Palek, Sobia Manzoor, Vaclav Liska. A Double Edged Sword Role of Interleukin-22 in Wound Healing and Tissue Regeneration. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.02148
|
| 39 |
Minjie Wan, Jiawen Han, Lili Ding, Feng Hu, Pujun Gao. Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.604894
|
| 40 |
Jingyan Li, Bingmin Wu, Lishan Zeng, Ying Lin, Qiuhe Chen, Haixia Wang, Lin An, Jiajun Zhang, Siyan Chen, Junying Huang, Ruoting Zhan, Guifang Zhang. Aqueous extract of Amydrium sinense (Engl.) H. Li alleviates hepatic fibrosis by suppressing hepatic stellate cell activation through inhibiting Stat3 signaling. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1101703
|
| 41 |
Kunj Vyas, Mayur M Patel. Insights on drug and gene delivery systems in liver fibrosis. Asian Journal of Pharmaceutical Sciences 2023; 18(2): 100779 doi: 10.1016/j.ajps.2023.100779
|
| 42 |
Rodrigo F. Carmo, Maria S.M. Cavalcanti, Patrícia Moura. Role of Interleukin-22 in chronic liver injury. Cytokine 2017; 98: 107 doi: 10.1016/j.cyto.2016.08.023
|
| 43 |
Si-Biao Su, Wen Chen, Fei-Fei Huang, Jian-Feng Zhang. Elevated Th22 cells correlated with Th17 cells in patients with high liver stiffness in nonalcoholic fatty liver disease. European Journal of Inflammation 2018; 16: 205873921880267 doi: 10.1177/2058739218802678
|
| 44 |
Hedyeh Ebrahimi, Mohammadreza Naderian, Amir Ali Sohrabpour. New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article. Middle East Journal of Digestive Diseases 2018; 10(3): 133 doi: 10.15171/mejdd.2018.103
|
| 45 |
Heng Zhou, Guomin Xie, Yudi Mao, Ke Zhou, Ruixue Ren, Qihong Zhao, Hua Wang, Shi Yin. Enhanced Regeneration and Hepatoprotective Effects of Interleukin 22 Fusion Protein on a Predamaged Liver Undergoing Partial Hepatectomy. Journal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/5241526
|
| 46 |
Xiaoni Kong, Wenjun Liu, Qiang Xia, Fouad Lafdil. Physiological and Pathological Properties of Interleukin-22 in Liver Diseases. Current Pathobiology Reports 2015; 3(4): 307 doi: 10.1007/s40139-015-0088-9
|
| 47 |
Kaiping Wang, Junfeng Wang, Mengzi Song, Hanxiang Wang, Ni Xia, Yu Zhang. Angelica sinensis polysaccharide attenuates CCl4-induced liver fibrosis via the IL-22/STAT3 pathway. International Journal of Biological Macromolecules 2020; 162: 273 doi: 10.1016/j.ijbiomac.2020.06.166
|
| 48 |
Jia Chen, RathnaSilviya Lodi, Shiqing Zhang, Zhaoliang Su, Yan Wu, Lin Xia. The double-edged role of IL-22 in organ fibrosis. Immunopharmacology and Immunotoxicology 2020; 42(5): 392 doi: 10.1080/08923973.2020.1799388
|
| 49 |
Shi Yin, Dechun Feng. Interleukin-22 in the pathogenesis and potential treatment of liver diseases. Liver Research 2017; 1(3): 181 doi: 10.1016/j.livres.2017.09.003
|